As of September 2022, 15 percent of new medicines in the R&D pipeline worldwide were medicines for infectious diseases, while immunology medicines accounted for four percent of new medicines in the R&D pipeline. This graph illustrates the distribution of new medicines in the R&D pipeline worldwide, by therapeutic class.
Distribution of new medicines in the R&D pipeline worldwide as of 2022, by therapeutic class
Includes all pipeline medicines (all stages) that are being developed for market in Canada, the United States, or geographic Europe (excluding Russia and Turkey).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PMPRB. (June 1, 2023). Distribution of new medicines in the R&D pipeline worldwide as of 2022, by therapeutic class [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB. "Distribution of new medicines in the R&D pipeline worldwide as of 2022, by therapeutic class." Chart. June 1, 2023. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB. (2023). Distribution of new medicines in the R&D pipeline worldwide as of 2022, by therapeutic class. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB. "Distribution of New Medicines in The R&d Pipeline Worldwide as of 2022, by Therapeutic Class." Statista, Statista Inc., 1 Jun 2023, https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/
PMPRB, Distribution of new medicines in the R&D pipeline worldwide as of 2022, by therapeutic class Statista, https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/ (last visited July 22, 2024)
Distribution of new medicines in the R&D pipeline worldwide as of 2022, by therapeutic class [Graph], PMPRB, June 1, 2023. [Online]. Available: https://www.statista.com/statistics/1335988/new-medicines-randd-pipeline-worldwide-share-by-class/